In this episode of On the Edge of Breakthrough, host Dr. Monty Pal sits down with Dr. Charles Brenner, an internationally recognized expert in metabolism and the founding Chair of the Department of Diabetes & Cancer Metabolism at City of Hope. Together, they explore the metabolic links between diabetes, obesity, and cancer, and how understanding those connections could lead to new ways to prevent and treat multiple diseases.

Dr. Brenner shares insights from his research into lean fatty liver disease (otherwise known as metabolic dysfunction-associated steatotic liver disease or MASLD), and how certain genetic factors may be quietly driving both metabolic dysfunction and cancer risk. They also discuss the rise of GLP-1 therapies and how a new class of compounds targeting FGF21 might offer a potential new therapeutic option that could help curb sugar cravings and support liver health.

This episode takes listeners deep into the science of energy balance, NAD metabolism, fatty liver disease, and what it truly means to be on the edge of a breakthrough.

Tune in now and stay updated on the science shaping the future of cancer care.

LinkedIn @city-of-hope
X @cityofhope
Facebook @cityofhope
Instagram @cityofhope

Presented by City Of Hope
www.CityOfHope.org